Nateglinide
- Product NDC
- 60687-684
- 11-digit product format
- 606870684
- Labeler code
- 60687
- Product ID
- 60687-684_2b2511ab-0768-113f-e063-6394a90a809d
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- nateglinide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- American Health Packaging
- Application
- ANDA077463
- Marketing category
- ANDA
- Marketing start
- 2023-01-03
- Substance
- NATEGLINIDE
- Active strength
- 120 mg/1
- Pharmacologic classes
- Glinide [EPC], Potassium Channel Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Nateglinide
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| NATEGLINIDE | 120 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 41X3PWK4O2 |
| Rxcui | 311919, 314142 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 60687-684-11 | Nateglinide | 1 in 1 BLISTER PACK | TABLET | 1 | | 5 |
| 60687-684-21 | Nateglinide | 30 in 1 CARTON | TABLET | 30 | | 5 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 60687-684 | NATEGLINIDE TABLET [AMERICAN HEALTH PACKAGING] | 5 | Current NDC, Legacy NDC, 2 package rows | 20250109_b17ead66-dc11-4e54-9ba6-00619510f27b.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 60687-684-11 | 60687068411 | 1 in 1 BLISTER PACK | | | | | | Historical |
| 60687-684-21 | 60687068421 | 30 BLISTER PACK in 1 CARTON (60687-684-21) / 1 TABLET in 1 BLISTER PACK (60687-684-11) | 30 blister pack | 2023-01-03 | 0000-00-00 | No | No | Current |